Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",22035,170,0.90 [0.75-1.08],0.2773825382060351
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",23036,182,1.05 [0.88-1.24],0.5956201273163219
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",22787,1367,1.02 [0.96-1.09],0.4463179342843286
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Candidiasis,23046,364,1.10 [0.98-1.24],0.101283269153538
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,22368,3368,1.03 [0.99-1.07],0.2130562201653724
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),22344,3408,1.00 [0.96-1.04],0.914027272421966
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,22843,1016,1.02 [0.95-1.10],0.592263916124331
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,22974,78,0.74 [0.56-0.98],0.0363859005894996
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,20873,1082,0.99 [0.92-1.06],0.7813148410492705
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,20157,1208,1.00 [0.93-1.07],0.9009159632922816
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,19873,242,1.11 [0.96-1.28],0.1537859861784191
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,16227,2212,1.00 [0.95-1.05],0.9849302031195466
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,19804,390,1.10 [0.98-1.23],0.1114704934897398
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,23037,1210,1.03 [0.96-1.10],0.4307547279240701
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Mycoses,23131,449,1.07 [0.96-1.19],0.2487465205833116
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,22289,869,1.02 [0.95-1.11],0.547731449995876
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,23058,1193,0.97 [0.91-1.04],0.4059966089423354
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,22010,183,1.04 [0.87-1.23],0.6742259174012613
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,23170,52,1.23 [0.91-1.66],0.1814882995967459
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Other septicaemia,22908,1043,0.98 [0.91-1.05],0.61261239075964
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,22962,66,1.30 [1.00-1.70],0.0481246397017301
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Other viral diseases,23111,114,1.24 [1.01-1.53],0.0362603359137226
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23093,96,1.34 [1.08-1.67],0.0082463136480552
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,21894,474,1.09 [0.98-1.21],0.0977071953050625
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,21694,274,1.01 [0.88-1.16],0.8879636884285605
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,21911,84,0.96 [0.75-1.24],0.7657704279715591
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,23151,66,0.93 [0.70-1.24],0.6390290707031638
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,23116,139,0.93 [0.76-1.13],0.4623746608593474
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Viral warts,23028,51,0.99 [0.72-1.37],0.965505001582968
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],23025,48,0.84 [0.59-1.20],0.3380687684667784
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign lipomatous neoplasm,22864,334,0.91 [0.80-1.04],0.1768518163598253
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,23100,44,1.05 [0.74-1.47],0.7949640489964682
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,23067,52,1.06 [0.78-1.45],0.7084697975168799
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,23124,127,0.86 [0.69-1.06],0.1587828103972305
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",22805,1595,1.02 [0.96-1.08],0.5131725453490728
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign neoplasm of meninges,23171,33,1.24 [0.85-1.82],0.2599133902723824
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,23109,63,0.85 [0.63-1.15],0.3034669712149005
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,23154,70,1.02 [0.78-1.34],0.8795261413316225
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign neoplasm: Ascending colon,23145,427,1.03 [0.92-1.15],0.6470140817348049
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign neoplasm: Caecum,23141,339,1.01 [0.89-1.15],0.8525081295959914
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",23043,79,0.93 [0.71-1.21],0.5745583366737116
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign neoplasm: Descending colon,23137,267,1.09 [0.95-1.25],0.2154956037657312
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign neoplasm: Rectum,23100,403,0.93 [0.83-1.04],0.2203552249039277
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,23050,706,1.05 [0.97-1.15],0.2353824657125763
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign neoplasm: Transverse colon,23127,542,1.09 [0.99-1.20],0.0952226692076818
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",18014,68,0.93 [0.70-1.24],0.6278661243985069
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",18013,67,0.77 [0.57-1.04],0.0917987046763016
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",23140,95,1.08 [0.86-1.36],0.513981203411391
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Haemangioma, any site",23140,92,1.11 [0.87-1.40],0.3992445436073893
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Lung cancer and mesothelioma,15439,337,1.10 [0.97-1.25],0.1342772414117797
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Lymphoid leukaemia,18008,62,0.95 [0.71-1.29],0.756796357391068
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",18138,192,1.14 [0.97-1.34],0.122746785790625
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",18230,284,0.98 [0.85-1.12],0.7455315776585314
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",18032,86,0.93 [0.72-1.20],0.5800526218528228
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",18082,136,1.01 [0.83-1.24],0.9062113612438112
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",18081,135,0.97 [0.80-1.19],0.8001905453301571
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",18024,78,0.88 [0.67-1.16],0.3627474828553805
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",19303,1357,0.97 [0.91-1.04],0.3972084633770812
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",18086,140,0.95 [0.78-1.16],0.6087827971991404
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",18046,100,1.15 [0.92-1.43],0.2280238769544062
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,18072,126,1.07 [0.88-1.32],0.4958370167365896
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Melanocytic naevi,23046,166,0.81 [0.67-0.97],0.0250732840778562
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Melanocytic naevi of trunk,23139,91,0.95 [0.75-1.22],0.7123569474834885
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Melanoma in situ,17977,71,1.10 [0.84-1.44],0.4882697696580861
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",18043,97,0.80 [0.62-1.02],0.0716536329407765
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",18107,161,0.89 [0.74-1.08],0.2372043337280496
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",18160,214,1.10 [0.94-1.28],0.2278006731027027
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",18045,99,0.93 [0.73-1.18],0.5618005220944056
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Other benign neoplasms of skin,23038,130,1.02 [0.83-1.24],0.8757107397266445
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",19114,1168,0.97 [0.91-1.04],0.4212933557769963
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",19188,1242,0.99 [0.92-1.05],0.693006254548439
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,22913,299,0.89 [0.78-1.02],0.096981391050036
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,21478,113,0.88 [0.70-1.10],0.2617213630461819
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,22680,66,1.05 [0.79-1.39],0.7437320867689272
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,22628,2704,0.99 [0.95-1.04],0.8113147797168175
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,21927,60,1.20 [0.90-1.59],0.2087931636182501
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,22753,52,0.80 [0.57-1.12],0.1920587689300749
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,22800,1435,1.02 [0.96-1.08],0.6228307812606393
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,22799,1434,1.01 [0.95-1.08],0.6669272985714645
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,21465,100,0.94 [0.74-1.19],0.6034846598436803
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,22937,1070,1.03 [0.96-1.10],0.4398294703517693
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,22804,103,0.96 [0.76-1.20],0.7027782071148949
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,22686,72,1.05 [0.80-1.37],0.7212868204502574
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,22673,59,1.19 [0.89-1.59],0.2316590728249726
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,23011,310,0.71 [0.62-0.82],2.138507337636755e-06
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,23079,47,0.87 [0.62-1.23],0.4390731750964037
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",22954,253,0.66 [0.57-0.78],5.080125529819594e-07
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,21941,74,0.92 [0.70-1.22],0.5782217348789874
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,17090,368,0.95 [0.84-1.07],0.3754663362294423
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,21186,158,1.17 [0.98-1.39],0.077636972032856
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,21208,180,1.08 [0.92-1.28],0.3425045645990449
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,16777,55,1.03 [0.76-1.41],0.8297337365450044
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,21840,64,0.74 [0.54-1.01],0.0566946802251066
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,21088,216,0.93 [0.79-1.09],0.3881732912839527
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",22676,605,0.99 [0.90-1.09],0.8333230318156628
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,22308,237,0.95 [0.82-1.11],0.5479532472105624
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,22239,168,1.19 [1.00-1.41],0.0536539588610187
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,22876,1100,1.08 [1.01-1.15],0.0338364398342942
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,19810,1056,1.08 [1.01-1.16],0.0318773328605941
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",16794,72,0.66 [0.49-0.89],0.0064095291454085
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",22311,37,0.87 [0.59-1.29],0.4933948175272311
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,16987,265,1.23 [1.08-1.41],0.0022412066468193
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,16791,69,1.24 [0.95-1.61],0.1068802050032483
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,20489,3767,1.06 [1.03-1.10],0.001122063179455
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,16899,177,1.07 [0.90-1.27],0.427876862665966
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,17270,548,1.13 [1.03-1.25],0.0097101678430719
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,23113,267,0.98 [0.85-1.13],0.8311832117960911
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,22930,84,0.81 [0.62-1.05],0.1177973839819885
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,16870,148,1.18 [0.99-1.41],0.0721453991253726
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",16784,62,0.95 [0.70-1.28],0.726631034911705
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,22995,721,0.98 [0.90-1.07],0.5952193094362145
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,17022,300,1.08 [0.95-1.23],0.246313004083763
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,17089,367,0.89 [0.78-1.01],0.0619653489532813
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",17428,706,1.10 [1.01-1.19],0.0378105778185436
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,16864,142,0.86 [0.70-1.06],0.1570228378112606
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,22924,78,0.84 [0.64-1.10],0.1976272972295786
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,17279,557,1.11 [1.01-1.22],0.0325464791283705
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,17103,381,1.03 [0.92-1.16],0.6232871725978628
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,20940,68,0.92 [0.69-1.23],0.5751813818374045
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,21762,5040,1.04 [1.01-1.08],0.008443839311852
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,22294,20,0.82 [0.48-1.40],0.4642000893294247
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,22295,21,0.86 [0.51-1.45],0.5813177862692729
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,23001,1722,0.93 [0.88-0.98],0.0079134308983428
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",22998,1718,0.93 [0.88-0.98],0.0094106280807086
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,22295,21,1.44 [0.92-2.26],0.1082424264854584
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,22908,779,1.01 [0.93-1.10],0.79078062335398
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",18299,1577,1.01 [0.96-1.07],0.6529371431724804
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,23159,262,0.96 [0.83-1.11],0.5952288651376045
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,22178,107,1.00 [0.80-1.25],0.9890331411354636
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,22202,73,0.99 [0.76-1.30],0.9678919421521968
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,22210,81,1.24 [0.98-1.58],0.0779510938055421
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",16787,65,1.18 [0.89-1.55],0.2546446322448535
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,20467,160,0.93 [0.77-1.12],0.4408354300988344
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,2421,119,0.98 [0.79-1.21],0.8219233857817732
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,2579,308,0.90 [0.79-1.03],0.127073174718989
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,20402,95,0.90 [0.72-1.13],0.374599347928419
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,2379,79,0.82 [0.62-1.08],0.1642502025675343
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,22405,2098,1.02 [0.97-1.07],0.3924032179629083
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,22427,356,0.90 [0.79-1.02],0.1074512031529121
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,21108,236,1.01 [0.87-1.17],0.9153116723035896
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,17499,777,1.04 [0.96-1.13],0.3332515896938417
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",23048,246,0.93 [0.80-1.08],0.3219209957991633
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),21983,270,0.85 [0.74-0.98],0.0299743791617222
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Angina pectoris,20318,1461,0.95 [0.89-1.01],0.0828465969614633
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Aortic aneurysm,22088,375,0.91 [0.81-1.03],0.1366431689657899
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,21796,83,1.10 [0.86-1.40],0.4424645711158498
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",21955,242,1.06 [0.91-1.22],0.458326706442861
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,13569,2245,0.94 [0.89-0.99],0.0120983411170041
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,AV-block,18637,599,0.98 [0.89-1.07],0.6097042291221101
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",23097,523,0.92 [0.83-1.02],0.1344034404983302
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Cardiac arrest,11575,251,1.04 [0.90-1.21],0.5558877672189002
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Cardiomyopathy,18235,197,0.98 [0.83-1.15],0.7893825029925309
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",18146,108,0.98 [0.78-1.23],0.8724706727884185
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,23172,66,1.31 [1.00-1.70],0.049309255415945
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Conduction disorders,19352,1314,0.97 [0.91-1.03],0.3282784596406385
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,21399,2565,1.03 [0.98-1.07],0.2532306406264902
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,19502,7526,1.03 [1.00-1.05],0.0650414916657713
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,DVT of lower extremities,21984,270,0.92 [0.80-1.06],0.2686381106228404
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Endocarditis,18119,81,1.07 [0.83-1.39],0.5835276121450741
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Heart failure, strict",22867,1290,0.98 [0.91-1.04],0.4714261180836563
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Hypertension,20666,6561,1.04 [1.01-1.07],0.0099536669005137
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Hypertension, essential",20688,6583,1.04 [1.01-1.07],0.010338914807547
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Hypertension, portal",22952,103,0.87 [0.69-1.10],0.2455239675287243
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",14282,177,0.99 [0.83-1.19],0.9383552629723422
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,14270,165,0.96 [0.80-1.15],0.6534485533848535
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Hypotension,23025,1202,1.07 [1.01-1.15],0.0318987840720769
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,22127,116,0.87 [0.70-1.09],0.227420665451653
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",21536,2679,1.02 [0.98-1.07],0.3476814886806122
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",22749,632,1.10 [1.00-1.20],0.04218645284107
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Left bundle-branch block,18443,405,1.01 [0.90-1.13],0.9239822778411734
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,22460,1037,1.02 [0.95-1.10],0.5274052278905849
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",19756,899,1.05 [0.97-1.13],0.2209672046425408
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",23015,212,1.08 [0.92-1.26],0.3385149793724414
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",23119,367,0.95 [0.84-1.07],0.3778205282327129
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Oesophageal varices,21779,65,0.81 [0.60-1.09],0.1662615263606263
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Other aneurysm,21808,95,0.96 [0.76-1.22],0.7375856906758611
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Other arrhythmias,18505,467,1.01 [0.90-1.12],0.8867745937000456
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,21847,134,1.11 [0.92-1.35],0.2657239672322907
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,21982,269,0.95 [0.82-1.09],0.4503589393064314
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,18228,190,0.94 [0.79-1.12],0.4992087851228515
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Other disorders of veins,21811,97,0.93 [0.73-1.18],0.5445939961781034
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,21762,48,0.98 [0.71-1.37],0.9184224494763612
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,21621,84,1.00 [0.78-1.29],0.9905944556832263
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,21818,104,0.94 [0.75-1.18],0.5870475325866223
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,19250,1212,0.94 [0.88-1.01],0.0752867054198823
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,21886,63,0.94 [0.70-1.27],0.7006339891109852
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,22274,561,1.06 [0.97-1.17],0.2114414481308794
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,22538,351,1.02 [0.90-1.16],0.7232961336509426
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",22184,647,1.06 [0.97-1.16],0.1910599999247051
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,11695,371,0.86 [0.76-0.98],0.0205543163966955
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Peripheral artery disease,22183,515,1.00 [0.90-1.10],0.9467987870627056
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),22064,350,0.94 [0.83-1.06],0.3244469002410895
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Pulmonary embolism,22676,489,0.93 [0.84-1.04],0.2114418249725412
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,23108,690,0.96 [0.88-1.05],0.4076609901933419
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Right bundle-branch block,18495,457,0.95 [0.85-1.06],0.3594961680985663
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Secondary right heart disease,22536,349,1.02 [0.90-1.15],0.7776085241487822
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,21755,218,1.09 [0.93-1.27],0.272111948320698
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",22733,722,1.07 [0.98-1.17],0.1129913762805862
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",22718,750,1.07 [0.98-1.16],0.1268470259519648
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,22108,46,0.87 [0.61-1.24],0.4520890194634132
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,21823,111,0.80 [0.64-1.01],0.0592609637986381
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Transient ischemic attack,22360,243,1.06 [0.92-1.23],0.412220961419516
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,21728,305,0.95 [0.83-1.09],0.4481351167479904
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Varicose veins,22081,367,0.97 [0.86-1.10],0.6361720288837027
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,21731,73,0.88 [0.67-1.16],0.3747147496637606
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Venous thromboembolism,22936,767,0.92 [0.85-1.01],0.0693815817622998
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",22978,482,1.07 [0.97-1.18],0.1987626508279126
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",19913,943,1.05 [0.98-1.13],0.1673630211414757
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,Any mental disorder,22506,3536,1.04 [1.00-1.08],0.0411127974584961
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",22918,569,1.06 [0.97-1.17],0.2167771749452723
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",20105,1135,1.06 [0.99-1.14],0.0796915545556178
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",19054,84,1.19 [0.94-1.52],0.1476983869889082
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,Smoking dependency,22541,1490,1.07 [1.01-1.13],0.0234027233744625
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",20784,1814,1.07 [1.01-1.12],0.0149095571185765
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,Vascular dementia,22668,150,0.92 [0.76-1.12],0.3967718732537355
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Alzheimer disease,23170,291,1.01 [0.88-1.16],0.8358593215691176
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,"Alzheimer√ïs disease (Atypical or mixed), excluding more controls",15404,57,1.07 [0.79-1.46],0.6471956599567188
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Bell's palsy,21849,71,0.98 [0.75-1.29],0.8962610363352158
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,22104,326,1.08 [0.95-1.23],0.2196610979686245
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Cerebral cysts,22781,231,1.02 [0.87-1.18],0.8341496543846216
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,23087,354,0.99 [0.88-1.12],0.9245916469838128
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,22672,57,1.25 [0.93-1.67],0.1349676251222456
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,23153,74,0.80 [0.60-1.06],0.1245132628049385
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",22639,89,1.07 [0.84-1.36],0.5711528000719286
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Epilepsy,21601,274,1.00 [0.87-1.14],0.953160231477238
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,22645,1318,1.02 [0.96-1.09],0.4652169438404183
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,23134,675,1.01 [0.92-1.10],0.8729040869436803
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Falls/tendency to fall,22642,2163,0.98 [0.94-1.03],0.5292117453023446
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Generalized epilepsy,22800,58,1.13 [0.85-1.51],0.3945138488053065
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Hemiplegia,23004,271,1.01 [0.88-1.16],0.9065151100728616
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Hydrocephalus,22605,55,1.16 [0.86-1.56],0.3404159242011475
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,23152,54,1.14 [0.85-1.55],0.3842651856188933
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,21799,21,0.50 [0.28-0.90],0.0202994411705833
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,21866,88,1.00 [0.78-1.28],0.9999654538295548
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Memory loss,22510,118,0.85 [0.68-1.06],0.1489935905690595
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Migraine,21522,195,1.01 [0.86-1.19],0.8826051432141395
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23146,176,1.05 [0.89-1.25],0.5702041945360653
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Motor neuron disease,15504,145,1.14 [0.95-1.38],0.1661080232440734
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23062,60,0.99 [0.73-1.32],0.9207018708185926
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",22710,932,1.03 [0.96-1.11],0.3935886737385425
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Neurological diseases,21891,3560,1.02 [0.98-1.06],0.2523920090285709
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,22852,237,1.04 [0.89-1.20],0.644161725563833
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",22159,381,1.06 [0.95-1.20],0.2904935184885021
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",23078,342,1.00 [0.88-1.13],0.999945913132444
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,18180,606,1.07 [0.97-1.17],0.1819816973990654
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,22625,75,0.85 [0.64-1.12],0.2487572384742235
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Other disorders of nervous system,22701,151,0.88 [0.73-1.07],0.2088063437549395
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,22598,139,1.02 [0.84-1.24],0.8675497453608628
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Other facial nerve disorders,21866,88,0.97 [0.76-1.24],0.8204955752104899
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Other headache syndromes,21362,35,0.97 [0.66-1.44],0.8870284601478162
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Other neurological diseases,23059,509,1.01 [0.91-1.11],0.9142050288428416
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Other sleep disorders,22007,680,1.02 [0.94-1.12],0.5894778108053897
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Parkinson's disease,23148,528,1.02 [0.92-1.13],0.7246475859682042
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,22576,26,0.82 [0.51-1.32],0.4177829245539903
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Restless leg syndrome,23170,51,1.09 [0.80-1.50],0.579866291952094
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Sleep apnoea,22872,613,1.03 [0.94-1.12],0.5907581534678255
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Small fibre neuropathy,22789,53,1.02 [0.75-1.41],0.8822516843861667
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,23155,169,1.17 [0.99-1.39],0.0689616219048726
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,21810,32,0.99 [0.65-1.49],0.94520430089
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,23170,294,1.01 [0.88-1.16],0.895994596940897
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),22640,146,0.92 [0.76-1.12],0.426658717310852
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,22636,85,1.34 [1.06-1.68],0.0125352565134833
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,22837,294,0.95 [0.83-1.09],0.4923761860322611
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,22973,285,0.88 [0.76-1.01],0.0719339106076535
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,22322,42,0.99 [0.69-1.42],0.9367246389923718
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,22340,60,1.46 [1.13-1.90],0.0045231997769148
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",23079,41,0.86 [0.59-1.25],0.438711044135849
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,22943,123,1.06 [0.86-1.30],0.5901089389053307
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",2383,81,0.80 [0.61-1.06],0.1208400967247285
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,2910,127,1.04 [0.85-1.27],0.7180841776976934
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,22642,91,1.25 [1.00-1.57],0.0524029896589672
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,22927,970,0.98 [0.91-1.06],0.625691383825996
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",22873,593,1.03 [0.94-1.13],0.544633786474419
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,22424,144,1.12 [0.92-1.35],0.2618601697467093
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",23098,555,0.99 [0.90-1.10],0.9098804730466804
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,23167,64,1.20 [0.91-1.58],0.1872784766574752
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,23031,488,0.98 [0.88-1.09],0.7117624350792009
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",23131,311,1.00 [0.88-1.14],0.9913960786615502
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,23083,148,1.22 [1.02-1.46],0.0320623532251473
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,22354,74,1.00 [0.76-1.31],0.9998118082622328
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,22361,81,0.90 [0.69-1.18],0.4535041691243484
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,22324,44,1.05 [0.74-1.49],0.7955257025436562
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,23080,659,1.04 [0.95-1.13],0.4264782786696037
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,22598,177,1.02 [0.85-1.21],0.8606954371611855
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,22572,29,0.62 [0.39-1.00],0.052343783031781
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,22912,92,0.88 [0.68-1.13],0.3053843627112227
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,23045,225,1.02 [0.87-1.19],0.7933131943530939
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,22707,164,1.09 [0.91-1.30],0.3366900652296529
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,23019,84,1.26 [0.99-1.60],0.0612937170712176
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,22868,447,1.08 [0.97-1.21],0.1437586642345985
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,22675,124,1.16 [0.95-1.41],0.1470098083794279
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,21824,1729,1.03 [0.97-1.08],0.3747781596010228
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,23014,194,1.03 [0.87-1.21],0.7707013828763919
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,23156,144,1.13 [0.94-1.37],0.1899676673556947
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,22680,400,0.96 [0.85-1.07],0.4451546179287406
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,22882,62,0.80 [0.58-1.09],0.1505472151060608
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,23158,55,1.17 [0.86-1.57],0.3123883127512555
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,22350,70,0.84 [0.63-1.12],0.2393756707081404
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,22416,136,0.97 [0.79-1.18],0.7458790078103432
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,22083,126,1.05 [0.86-1.29],0.6127395839847343
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,22592,49,0.93 [0.67-1.31],0.6928941751366428
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",22019,62,0.95 [0.70-1.29],0.7373017655372653
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,22472,51,0.93 [0.67-1.30],0.6790166392377763
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",22620,199,0.99 [0.84-1.17],0.9199859024565268
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,22392,112,0.95 [0.76-1.18],0.6217625431355653
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,22073,116,1.21 [0.98-1.48],0.0715875039438504
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,22045,88,0.81 [0.62-1.05],0.1054425757837251
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,21531,1436,1.01 [0.95-1.07],0.7823149678034689
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,22337,57,0.97 [0.71-1.33],0.8653330497809106
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,22930,379,1.18 [1.06-1.33],0.0033930868393794
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,22619,68,1.07 [0.82-1.41],0.6076301658961911
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),22716,165,1.13 [0.95-1.35],0.1538528041697247
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,22997,57,0.88 [0.64-1.21],0.4318051540909945
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,23127,118,1.02 [0.83-1.26],0.8313629864711167
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,23040,105,1.14 [0.92-1.41],0.2447209797235902
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,22988,48,1.06 [0.77-1.48],0.7121417843777491
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VIII Diseases of the ear and mastoid process,M¬éni¬ère disease,22991,51,1.12 [0.82-1.53],0.4776469353091266
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,23075,929,0.95 [0.88-1.03],0.1841754343476696
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,22836,690,0.95 [0.87-1.04],0.2641883593518107
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,22267,121,0.81 [0.65-1.02],0.0685277027971289
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,22228,82,1.14 [0.89-1.46],0.2898515827570014
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Acute pharyngitis,22962,60,0.80 [0.59-1.10],0.1647670777625717
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23087,185,0.89 [0.75-1.06],0.1849932625613012
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,22962,60,0.84 [0.62-1.14],0.2669400565842351
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,All influenza,20950,103,1.05 [0.84-1.32],0.6683255877932314
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),20947,100,1.08 [0.86-1.36],0.4815232580037357
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Allergic asthma (mode),15203,101,0.98 [0.78-1.24],0.8928091327048316
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Allergic rhinitis,23064,257,0.92 [0.79-1.06],0.2635702467850329
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",16152,1386,1.04 [0.98-1.11],0.1905518725388413
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",16463,1361,1.05 [0.98-1.11],0.1486797766613109
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),22800,147,1.08 [0.90-1.31],0.3934838950213398
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",20941,94,1.09 [0.87-1.38],0.4472866443602055
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Bronchiectasis,20160,281,1.01 [0.88-1.16],0.8920949331073105
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",19921,42,1.40 [1.03-1.91],0.0316979821265197
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,22353,2474,1.04 [0.99-1.09],0.0907569078924223
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",21765,75,1.18 [0.91-1.52],0.2038532609247441
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Chronic sinusitis,21846,156,1.23 [1.03-1.46],0.0190608970931351
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",22953,1264,1.03 [0.97-1.10],0.3004655732820637
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Deviated nasal septum,21828,138,0.99 [0.81-1.20],0.8880967638787067
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,21223,5124,1.03 [0.99-1.06],0.1185195630098367
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",22073,383,1.00 [0.89-1.13],0.9850140184361338
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Early onset COPD,21985,296,1.07 [0.95-1.21],0.2809799970337832
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Emphysema,20218,339,1.13 [1.01-1.27],0.0379373877604176
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,22269,323,1.06 [0.93-1.20],0.3750740811745466
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Influenza and pneumonia,22928,2081,1.04 [0.99-1.10],0.0925538147440209
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Interstitial lung disease,22296,350,1.10 [0.97-1.24],0.1326666444282558
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Later onset COPD,22142,968,1.02 [0.95-1.10],0.622621521003313
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,23153,415,1.05 [0.94-1.17],0.4046785005645515
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Nasal polyp,21827,137,1.11 [0.92-1.35],0.2790362746477129
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,22904,959,1.07 [0.99-1.15],0.0728172553382744
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Other diseases of pleura,22898,2121,1.04 [0.99-1.10],0.0987426284116687
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,22533,843,1.01 [0.93-1.09],0.8156479236511774
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Other pleural conditions,20843,66,1.04 [0.79-1.39],0.7611972149647745
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,23078,431,1.11 [1.00-1.24],0.0604206336363879
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,23051,1351,1.06 [1.00-1.13],0.0501004701873339
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Pleural effusion,21854,1077,1.03 [0.96-1.11],0.3734253272686358
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Pleural plaque,21032,255,0.98 [0.85-1.14],0.8079009948221463
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",22670,1823,1.04 [0.99-1.10],0.1395272542379685
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,23056,318,1.05 [0.92-1.19],0.4988174021812901
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Pneumothorax,20916,139,0.89 [0.72-1.08],0.2385112204718444
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Pollen allergy,23155,225,0.97 [0.83-1.13],0.7004995519840524
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Pulmonary oedema,22714,67,1.08 [0.82-1.42],0.5834219103977077
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Respiratory insufficiency,15157,55,1.14 [0.84-1.54],0.4025598635218004
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,22889,944,1.07 [0.99-1.15],0.0760177907841148
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,21949,259,0.93 [0.80-1.07],0.306313203570616
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Viral pneumonia,21119,272,1.05 [0.92-1.21],0.4665372067759973
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",22817,231,1.00 [0.86-1.17],0.9637437473695296
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,10091,110,0.91 [0.72-1.14],0.3983384948198355
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,16190,89,1.20 [0.96-1.52],0.1155121588799417
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Acute appendicitis,23044,140,1.14 [0.94-1.37],0.1723203981243421
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Acute gastritis,17502,89,1.15 [0.91-1.45],0.2560790811818738
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Acute pancreatitis,21871,186,0.99 [0.83-1.17],0.8622432308688204
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Acute peritonitis,22823,94,0.98 [0.77-1.24],0.8515646392869076
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Alcoholic liver disease,22314,111,0.95 [0.77-1.18],0.6537830379400693
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Barrett oesophagus,17923,510,0.94 [0.85-1.05],0.2815638446816921
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",21803,118,0.81 [0.65-1.02],0.0732236049158668
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",22778,118,0.81 [0.65-1.01],0.0655977824688603
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Cholecystitis,21892,207,0.86 [0.73-1.02],0.0805954652774001
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Cholelithiasis,22437,752,1.06 [0.97-1.15],0.1748251997572139
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Chronic gastritis,17670,257,0.93 [0.81-1.08],0.3640061819949526
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Chronic pancreatitis,21741,56,0.86 [0.63-1.18],0.3595090129494909
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",22974,125,0.82 [0.66-1.02],0.0764417985784601
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Coeliac disease,21584,91,1.22 [0.97-1.54],0.089718846455894
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Collagenous colitis,21783,48,1.15 [0.83-1.58],0.4001045606126586
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,23009,213,0.98 [0.83-1.14],0.7553973420778968
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Constipation,23015,1546,0.98 [0.92-1.04],0.4270409551338066
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Crohn disease,21823,88,1.15 [0.91-1.46],0.2425597155422759
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",22837,62,1.00 [0.75-1.34],0.9786217256307382
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Crohn's disease NAS,21810,75,1.27 [0.99-1.63],0.0566054247339072
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Dental caries,22548,217,1.19 [1.03-1.38],0.0219345382558713
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,19649,1889,1.01 [0.96-1.06],0.7738009051183731
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Diseases of appendix,23072,168,1.09 [0.92-1.30],0.3207909523869141
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Diseases of liver,23036,833,0.93 [0.86-1.01],0.0802899202730018
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",21225,3812,1.01 [0.97-1.05],0.7076264603748224
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",22821,490,1.08 [0.97-1.19],0.1444394184171801
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Diseases of peritoneum,23123,394,1.02 [0.91-1.15],0.6890867122842592
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,22436,105,1.10 [0.88-1.37],0.397851260997069
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Diseases of salivary glands,22299,65,1.00 [0.75-1.33],0.9795898201156144
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Diseases of the digestive system,22867,1374,1.06 [1.00-1.13],0.0672311028920218
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Diseases of tongue,22320,105,1.04 [0.84-1.30],0.7019469671827292
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",22812,1127,1.00 [0.93-1.07],0.9972306947600303
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,19059,2958,0.99 [0.95-1.04],0.7387302529582693
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Duodenal ulcer,17675,262,1.03 [0.90-1.19],0.6649331939163552
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",23060,205,1.00 [0.85-1.17],0.9957873929630872
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,23097,46,1.02 [0.73-1.43],0.91217866446182
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,22349,146,0.80 [0.66-0.98],0.0305752439464141
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,16277,176,0.96 [0.80-1.14],0.6230067965903783
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Functional dyspepsia,17828,415,0.96 [0.86-1.08],0.5206198921778908
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Gastric ulcer,17767,354,1.10 [0.98-1.24],0.1097881779068537
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,19493,2080,1.01 [0.96-1.06],0.6650533849426529
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,17994,581,1.05 [0.96-1.16],0.2792892580148558
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,17728,7750,1.00 [0.97-1.02],0.7790661769421662
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,GI-bleeding,22631,1138,1.03 [0.97-1.11],0.3214361850304844
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,22373,42,1.02 [0.72-1.45],0.9195364728630668
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,17038,1200,0.96 [0.89-1.02],0.206442388659649
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",22283,80,0.91 [0.70-1.19],0.5046613144783865
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Hernia,21185,3425,1.01 [0.97-1.05],0.7656998444958183
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Impacted teeth,23100,43,1.08 [0.76-1.52],0.6757054907750095
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Impaction of intestines,16148,47,0.91 [0.64-1.28],0.5794043088151641
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Inguinal hernia,19342,1582,1.01 [0.95-1.07],0.7140405859055599
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",17952,192,1.01 [0.85-1.20],0.9066237795104528
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,16189,88,0.95 [0.74-1.22],0.682475997556293
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Intestinal malabsorption,21597,104,1.26 [1.02-1.56],0.0352483729748578
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,16367,266,0.94 [0.82-1.09],0.4383225018563789
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,23128,365,0.99 [0.88-1.12],0.8591788583729194
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,22392,657,1.00 [0.91-1.09],0.9491985714301552
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,22591,856,1.01 [0.93-1.09],0.8661803229416847
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Oesophageal obstruction,17620,207,1.02 [0.87-1.19],0.8276200785257469
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Oesophagitis,18016,603,1.02 [0.92-1.11],0.7530500781459184
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,23119,111,1.04 [0.84-1.29],0.7322718464771281
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,17833,73,1.22 [0.94-1.58],0.1293944064419631
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,17491,1390,1.01 [0.95-1.08],0.6581546767750861
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,21937,252,0.92 [0.80-1.07],0.2909735195019671
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,21797,112,1.03 [0.83-1.28],0.7747070511988388
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of intestine,17925,1824,1.00 [0.95-1.06],0.9797825517598148
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of intestines,21411,5310,0.98 [0.95-1.01],0.2225399501618834
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,22282,174,1.09 [0.92-1.30],0.3104044368800537
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of liver,22866,663,0.93 [0.84-1.01],0.0938575529582422
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,18126,713,0.98 [0.90-1.07],0.6909012672004948
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of pancreas,21819,134,0.81 [0.66-1.00],0.0537726076512321
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,23054,325,1.06 [0.94-1.21],0.332390112926279
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,18189,776,0.98 [0.90-1.07],0.6641410467235125
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,22643,1150,1.04 [0.97-1.11],0.2889217554235018
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,22496,165,1.20 [1.01-1.42],0.0356507253457226
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,17682,1581,0.96 [0.91-1.02],0.2300735580524795
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),19232,1819,1.01 [0.96-1.07],0.5945231166440906
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,22295,92,0.75 [0.58-0.97],0.0269112663774695
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,22487,752,0.98 [0.90-1.06],0.6056148297508944
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",16441,340,0.96 [0.84-1.09],0.4815318629131301
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23089,55,1.05 [0.78-1.43],0.7381219076100372
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,16566,465,0.95 [0.85-1.06],0.3428518562022989
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",21653,160,1.21 [1.02-1.44],0.0278955300045929
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Recurring oral aphthae,23157,42,0.86 [0.59-1.24],0.4139550530598355
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,22339,99,1.15 [0.92-1.44],0.2078185111075257
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Toxic colitis,21777,42,0.61 [0.41-0.90],0.0141413244097102
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,17696,283,1.17 [1.03-1.34],0.0189742160754183
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Ulcerative colitis,21878,143,1.15 [0.96-1.39],0.1340251903576428
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",21855,120,1.07 [0.87-1.31],0.5464979762064619
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Umbilical hernia,18115,355,0.98 [0.87-1.11],0.8063374080619184
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,16254,153,0.90 [0.74-1.09],0.2877509552668349
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Ventral hernia,18011,251,1.02 [0.88-1.18],0.7829075350228091
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Volvulus,16175,74,0.86 [0.65-1.14],0.3094738908767779
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,23097,318,0.86 [0.75-0.99],0.0330385581798361
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,22860,65,1.19 [0.90-1.56],0.2156448721799833
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,21223,92,0.99 [0.78-1.27],0.9531017333969845
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,22443,727,1.00 [0.92-1.09],0.9787531319886504
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",21913,197,0.99 [0.84-1.16],0.8940568611977739
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,21592,461,1.06 [0.95-1.18],0.3147634817941744
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,22882,261,1.07 [0.93-1.23],0.3309620138937872
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,23082,461,1.06 [0.95-1.18],0.2789423947452244
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,22664,43,1.16 [0.83-1.63],0.3874958514490836
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,21719,3097,1.00 [0.96-1.05],0.8433170249472877
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,22734,398,1.07 [0.96-1.20],0.2323423762714885
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,22624,288,1.05 [0.92-1.21],0.434319790102828
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,22713,997,1.01 [0.94-1.08],0.8403807954322958
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",23161,30,0.90 [0.58-1.39],0.6382763022946234
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,21154,23,1.41 [0.92-2.17],0.1121056853376876
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,22392,56,1.06 [0.78-1.44],0.6996922582528791
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,22878,257,1.07 [0.93-1.23],0.3755059027077472
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,21602,471,0.96 [0.86-1.07],0.4447149278350593
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,21208,77,0.91 [0.69-1.20],0.5038672721245993
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,23103,83,1.13 [0.88-1.44],0.3296881223755853
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,21930,214,1.15 [0.99-1.34],0.0714951007336623
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,23006,211,1.05 [0.90-1.23],0.5282938949010381
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,22691,70,1.15 [0.88-1.49],0.3167736648426453
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,21196,65,0.87 [0.64-1.17],0.3468201757969894
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,22727,1596,0.99 [0.93-1.05],0.762773517597255
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",21639,508,0.96 [0.87-1.07],0.5007397016849116
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,21211,80,0.90 [0.69-1.18],0.4466080489682517
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,23085,290,1.09 [0.95-1.24],0.2173715610605339
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,22672,51,0.99 [0.72-1.37],0.9576991635141644
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,23049,254,1.10 [0.96-1.27],0.1778606312184009
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,23116,337,0.85 [0.74-0.97],0.0131829392899243
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,21216,85,1.00 [0.77-1.28],0.9717167054212684
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,21397,266,0.88 [0.76-1.02],0.1018710758359237
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,23109,330,0.85 [0.75-0.97],0.0187601927218447
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",21393,262,1.02 [0.88-1.17],0.8183094866553169
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,23144,124,1.12 [0.92-1.37],0.2746880112465794
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,19983,84,0.93 [0.72-1.20],0.5731514631842504
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,21137,4637,1.04 [1.01-1.08],0.0132402356093973
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,19770,3270,1.03 [0.99-1.07],0.1935377987896068
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,19968,69,0.86 [0.65-1.15],0.3187404122383465
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,20343,145,1.07 [0.89-1.29],0.4794436816777284
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,20340,142,1.09 [0.90-1.32],0.3891676285853561
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,22970,67,1.14 [0.88-1.49],0.3279009315686715
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",20277,79,0.92 [0.71-1.20],0.5478141936098395
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,17347,847,1.07 [0.99-1.16],0.1001968477391867
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",23056,147,1.09 [0.90-1.32],0.3632040967119262
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,20462,264,1.03 [0.90-1.19],0.6524997476469896
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,19712,6085,1.04 [1.01-1.07],0.0072225390741636
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,22136,88,0.75 [0.58-0.97],0.0297070523355407
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,20062,163,0.88 [0.73-1.06],0.1648395038318559
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,20324,425,1.06 [0.95-1.18],0.3243602112892606
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,22377,2179,1.02 [0.97-1.07],0.4387097727885025
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,20257,358,1.00 [0.89-1.13],0.9683632792558782
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,19951,52,1.30 [0.97-1.75],0.0743404463108727
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,19993,94,1.05 [0.83-1.32],0.7063847813693163
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,22858,28,1.03 [0.67-1.59],0.8938385205623537
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,17919,1419,1.02 [0.96-1.09],0.4475572046331781
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,17446,946,1.02 [0.95-1.10],0.5788326938690584
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",23038,933,1.03 [0.95-1.11],0.4712472149165807
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,16546,46,0.95 [0.67-1.35],0.7760444057728596
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),16579,79,1.13 [0.87-1.45],0.3611700867801117
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,20159,260,0.99 [0.85-1.14],0.8599231289142367
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,17108,608,1.09 [1.00-1.20],0.06011855609588
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,20238,40,1.19 [0.84-1.68],0.3354089879682965
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,20722,524,1.05 [0.95-1.16],0.3495262398646176
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,20460,262,1.01 [0.87-1.16],0.9073567312922232
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,17071,571,1.06 [0.96-1.16],0.2653638537257234
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,19963,64,1.12 [0.85-1.48],0.4315950972268636
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",19952,53,1.06 [0.78-1.45],0.7083795756006814
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,22137,89,0.95 [0.74-1.21],0.6811116094266633
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,22887,839,0.95 [0.87-1.03],0.1885849627811197
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,22433,385,0.90 [0.80-1.02],0.1050171097470083
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",23088,274,1.05 [0.92-1.21],0.4854640811697143
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,18331,1831,1.05 [0.99-1.11],0.0823827587175772
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,16551,51,0.89 [0.63-1.24],0.4755854325957983
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,19980,81,1.20 [0.94-1.53],0.1426550682628507
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,16552,52,0.98 [0.70-1.35],0.8865158212257728
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),16546,46,0.81 [0.57-1.15],0.242088802869289
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,22232,184,1.05 [0.89-1.24],0.5932049068046472
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,22206,158,0.98 [0.82-1.18],0.856325272189613
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,23135,85,1.05 [0.82-1.34],0.6966668131839492
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",21691,1493,1.02 [0.96-1.08],0.5233983262489975
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,19960,61,1.09 [0.82-1.46],0.5484288893097289
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),16540,40,1.13 [0.79-1.63],0.4992006480716978
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,20797,599,1.00 [0.91-1.10],0.9398720836661636
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,18162,1662,1.04 [0.98-1.10],0.1868718839296708
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,22881,51,1.07 [0.78-1.47],0.6768412574685057
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,23152,59,1.21 [0.91-1.62],0.1828977085563804
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,19977,78,1.01 [0.77-1.31],0.9650488765468054
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",20867,968,1.06 [0.98-1.14],0.1279884291659158
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,19991,92,0.94 [0.73-1.20],0.6007407918077119
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,17672,1172,1.02 [0.95-1.09],0.6220420122414649
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,22133,85,1.00 [0.78-1.29],0.9694911505410884
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,19940,41,1.15 [0.81-1.64],0.4224753130553371
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,20309,111,1.05 [0.85-1.31],0.6337127627539056
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,20396,497,1.00 [0.90-1.11],0.9392579493840696
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,23021,191,1.01 [0.85-1.19],0.93068755054939
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,20672,474,1.02 [0.91-1.13],0.7766819114934644
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,23097,269,1.02 [0.89-1.18],0.7355690947727208
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,23155,38,1.28 [0.90-1.82],0.1645469337283497
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,20044,145,1.01 [0.84-1.23],0.8906381607674901
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,19001,562,1.06 [0.96-1.17],0.255708697446951
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,20371,472,1.05 [0.95-1.17],0.3341886066779683
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],20225,326,0.98 [0.86-1.11],0.7068779289270225
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",16530,30,0.75 [0.48-1.18],0.2181292931270452
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,18697,2197,1.04 [0.99-1.09],0.1456739704844303
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,16937,437,0.96 [0.86-1.08],0.5247819702577351
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,22993,163,0.97 [0.80-1.16],0.7265151492227673
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",23096,46,0.88 [0.62-1.25],0.4809139053373775
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",21240,46,0.87 [0.61-1.24],0.4369504346572249
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,16561,61,1.18 [0.89-1.57],0.2462245353266391
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,20286,88,1.06 [0.83-1.36],0.6286127246026798
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,16782,282,1.05 [0.91-1.20],0.5076265723408435
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,20168,269,1.08 [0.94-1.24],0.2665600842102652
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,20408,210,1.12 [0.96-1.31],0.1580497567183689
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,20291,93,1.04 [0.82-1.32],0.7667836357171471
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,18402,30,1.31 [0.89-1.93],0.1770520796038814
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",23156,39,1.26 [0.89-1.78],0.1928998090984796
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,20410,511,1.03 [0.93-1.14],0.5905776152146966
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sj¬ögren],22848,18,1.09 [0.63-1.87],0.7622532779719093
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,22119,2220,1.03 [0.98-1.08],0.2164107716555657
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",20000,101,1.16 [0.93-1.45],0.1918651340063453
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,20691,493,1.07 [0.96-1.18],0.2211164295897755
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,22143,190,0.99 [0.84-1.18],0.953138913904388
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,20322,124,0.98 [0.80-1.22],0.8863281511557242
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,21478,1280,1.03 [0.96-1.10],0.4135827139351726
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,21000,802,1.02 [0.94-1.10],0.6973566467034049
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],19940,41,1.24 [0.88-1.75],0.2194051270607075
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,22868,38,1.14 [0.80-1.63],0.4694892870555558
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,20016,117,1.13 [0.92-1.39],0.2490289790959263
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,19920,21,0.83 [0.49-1.41],0.4990719141293408
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),16560,60,0.77 [0.56-1.05],0.1017749315437689
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Acute renal failure,22198,1818,0.99 [0.94-1.05],0.810053885489013
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,22711,387,1.03 [0.91-1.15],0.662468539872406
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,22458,134,0.89 [0.72-1.09],0.264319946127224
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,21875,1495,0.94 [0.89-1.00],0.0540891167507938
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,22922,82,0.82 [0.62-1.08],0.1521077785460251
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,22896,345,1.04 [0.92-1.18],0.5501294283079161
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Cystitis,20375,205,1.08 [0.92-1.27],0.3243092260531521
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Dialysis,20482,102,1.01 [0.80-1.27],0.9364557387414438
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,21916,3238,1.02 [0.98-1.06],0.3046733501959959
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,20858,5434,1.00 [0.97-1.04],0.831308541361939
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,22941,101,0.96 [0.76-1.21],0.7215383009146945
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Hydrocele,18876,198,0.93 [0.78-1.10],0.3867636200232873
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,20479,357,1.03 [0.91-1.17],0.5967447029606258
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,21216,2538,1.02 [0.98-1.07],0.3150150004741656
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),18909,231,0.96 [0.82-1.12],0.5925548706586858
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,20243,73,0.94 [0.71-1.24],0.6703066493051455
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,18788,110,0.95 [0.76-1.19],0.6639151833791566
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",23159,58,1.09 [0.81-1.47],0.572703293558319
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",23164,54,0.86 [0.62-1.19],0.3675196110593582
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,22368,2198,1.02 [0.97-1.07],0.4236994517360586
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,21094,924,1.05 [0.97-1.13],0.2167122308232587
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,23097,546,1.02 [0.92-1.12],0.7667987471737889
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,18984,306,1.01 [0.88-1.15],0.8974915775894026
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,18957,279,0.97 [0.84-1.12],0.6745258580984944
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,18899,221,0.91 [0.77-1.07],0.2526205118881974
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,23153,46,0.94 [0.67-1.33],0.7429406387402571
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,21670,1500,1.03 [0.97-1.09],0.4033297426421985
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,20520,398,1.03 [0.91-1.15],0.6674011408217104
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,22737,186,0.95 [0.80-1.13],0.5691666455231422
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,22898,58,0.89 [0.65-1.22],0.4629990037826732
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",18940,262,1.08 [0.94-1.25],0.2661871045906178
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,22869,2747,0.98 [0.94-1.03],0.4924981408607665
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",20192,70,0.96 [0.72-1.27],0.759753520634164
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,20531,151,0.74 [0.60-0.90],0.0032845406277283
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,22397,73,0.98 [0.75-1.28],0.8712261370019746
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Urethral stricture,20458,288,0.99 [0.86-1.13],0.8601155478961612
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Urolithiasis,22823,499,0.98 [0.89-1.09],0.7471027216041446
